| Recruiting | A Study of LAD106 in Healthy Adult Participants Healthy Volunteers | Phase 1 | 2026-02-17 |
| Recruiting | A Study of LAD603 in Adults With Alopecia Areata Alopecia Areata | Phase 2 | 2025-12-17 |
| Not Yet Recruiting | A Study of LAD191 in Adults With Hidradenitis Suppurativa Hidradenitis Suppurativa | Phase 2 | 2025-09-01 |
| Recruiting | A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations i Atopic Dermatitis, Eczema | — | 2025-01-23 |
| Recruiting | A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis Dermatitis, Atopic, Eczema | Phase 3 | 2024-07-03 |
| Active Not Recruiting | A Study to Assess Patient-Reported Wellbeing Using Tildrakizumab in a Live Setting Plaque Psoriasis | — | 2024-04-04 |
| Completed | A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Kerato Keratosis, Actinic | Phase 3 | 2023-12-21 |
| Completed | A Single and Multiple Ascending Dose Study of LAD603 in Healthy Subjects Healthy Volunteers | Phase 1 | 2023-12-05 |
| Active Not Recruiting | Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic De Atopic Dermatitis, Eczema | Phase 3 | 2023-11-20 |
| Recruiting | A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO) Genital Psoriasis | — | 2023-11-14 |
| Recruiting | A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported O Plaque Psoriasis | — | 2023-09-06 |
| Completed | A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Plaque Psoriasis | — | 2023-06-13 |
| Active Not Recruiting | Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atop Atopic Dermatitis | Phase 3 | 2023-05-23 |
| Completed | A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses Actinic Keratosis | Phase 4 | 2023-01-20 |
| Active Not Recruiting | A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actini Keratosis, Actinic | Phase 4 | 2022-10-24 |
| Completed | Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune Disease Healthy Volunteers, Autoimmune Disease | Phase 1 | 2022-07-29 |
| Completed | A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis, Actinic | Phase 3 | 2022-06-28 |
| Completed | UV Sensor in Patients With Actinic Keratosis Keratosis, Actinic | — | 2022-06-13 |
| Completed | Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis Keratosis, Actinic | — | 2022-03-09 |
| Completed | A Study of Lebrikizumab in Combination With Topical Corticosteroids in Patients With Atopic Dermatitis (AD) Th Dermatitis, Atopic, Eczema | Phase 3 | 2021-12-23 |
| Completed | Observational Real-world Evidence (RWE) Study to Assess Patient-reported Wellbeing Using Tildrakizumab in Live Plaque Psoriasis | — | 2021-11-22 |
| Completed | Study of Pidotimod in Children With Recurrent Respiratory Tract Infections (RRI) Recurrent Respiratory Tract Infections | Phase 4 | 2021-08-04 |
| Completed | Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES) Acne Vulgaris | — | 2021-03-09 |
| Terminated | Long-Term Treatment Effect With Tildrakizumab in Participants With Plaque Psoriasis Plaque Psoriasis | Phase 4 | 2020-01-29 |
| Completed | Efficacy and Safety of Tildrakizumab 100 Milligrams (mg) in Participants With Moderate-Severe Chronic Plaque P Plaque Psoriasis | Phase 4 | 2019-12-17 |
| Completed | Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Plaque Psoriasis | — | 2019-10-30 |
| Completed | Efficacy and Safety of Tildrakizumab in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Who Are Plaque Psoriasis | Phase 4 | 2019-09-04 |
| Completed | A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp Actinic Keratoses | Phase 3 | 2017-09-18 |
| Completed | A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face o Actinic Keratosis | Phase 3 | 2017-09-15 |
| Completed | Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris Acne Vulgaris | Phase 4 | 2016-10-31 |
| Completed | Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008 Psoriasis | Phase 1 | 2016-09-01 |
| Completed | Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp Actinic Keratosis | Phase 2 | 2016-04-11 |
| Completed | A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris Acne Vulgaris | Phase 3 | 2015-03-20 |
| Completed | Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne Acne Vulgaris | Phase 3 | 2014-12-18 |
| Completed | Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment o Acne Vulgaris | Phase 3 | 2014-12-03 |
| Completed | Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic Keratose Actinic Keratosis | Phase 3 | 2014-10-01 |
| Completed | A Intra-individual Comparison to Investigate the Efficacy and the Safety of LAS41004 Formulation in Mild to Mo Psoriasis | Phase 2 | 2014-06-01 |
| Completed | Photoallergy Potential of Dapsone Gel in Healthy Volunteers Healthy Volunteers | Phase 1 | 2014-04-01 |
| Completed | Phototoxicity Test of Dapsone Gel in Healthy Volunteers Healthy Volunteers | Phase 1 | 2014-04-01 |
| Completed | Dermal Tolerability of Dapsone Gel in Healthy Volunteers Healthy Volunteers | Phase 1 | 2014-04-01 |
| Completed | Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque Test Psoriasis | Phase 1 / Phase 2 | 2014-03-01 |
| Completed | Efficacy and Safety of Tazarotene Gel in Nail Psoriasis Nail Psoriasis | Phase 2 | 2014-02-01 |
| Completed | A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris Acne Vulgaris | Phase 3 | 2013-11-01 |
| Completed | Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris Acne Vulgaris | Phase 3 | 2013-11-01 |
| Completed | A Single-dose, Randomised, Crossover, Placebo-controlled Study Assessing Two Fixed-dose Combinations of Inhale Asthma | Phase 1 | 2013-11-01 |
| Completed | Preference, Satisfaction and Ease of Use of Genuair® (Pressair™) and Breezhaler® (Neohaler™) Inhalers in Patie Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | 2013-07-01 |
| Completed | LAS41008 in Moderate to Severe Chronic Plaque Psoriasis Plaque Psoriasis | Phase 3 | 2012-11-01 |
| Completed | Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris | Phase 2 | 2012-06-30 |
| Completed | Neurophysiological Study of Sativex in Multiple Sclerosis (MS) Spasticity Multiple Sclerosis | Phase 3 | 2012-04-01 |
| Completed | Efficacy and Tolerability of LAS41004 Formulations in a Non-occlusive Psoriasis Plaque Test Psoriasis | Phase 2 | 2011-08-01 |
| Completed | Study Evaluating Preference, Satisfaction and Ease of Use of Inhalers in Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | 2011-06-01 |
| Completed | Exploratory Study to Investigate Efficacy of LAS41004 in a Psoriasis Plaque Test Psoriasis | Phase 2 | 2011-05-01 |
| Completed | LAS41005 in Hyperkeratotic Actinic Keratosis Actinic Keratosis | Phase 2 | 2011-04-01 |
| Completed | Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis Psoriasis | Phase 2 | 2011-01-01 |
| Completed | Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Actinic Keratosis | Phase 3 | 2010-11-01 |
| Completed | Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis Psoriasis | Phase 2 | 2010-07-01 |
| Completed | Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida Infections Candidiasis | Phase 2 | 2010-02-01 |
| Completed | Efficacy and Safety of LAS41003 in the Treatment of Inflammatory Tinea Pedis Tinea Pedis | Phase 2 | 2010-02-01 |
| Completed | Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema Atopic Eczema | Phase 2 | 2010-02-01 |
| Completed | Efficacy and Safety of LAS41003 in the Treatment of Superficial Infected Eczema Eczema | Phase 2 | 2009-11-01 |
| Completed | Efficacy and Safety Study of LAS41007 in the Treatment of Actinic Keratosis Actinic Keratosis | Phase 2 | 2009-08-01 |
| Completed | Standardized sTudy With Almotriptan in eaRly Treatment of Migraine Migraine | — | 2008-06-01 |
| Completed | Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis Actinic Keratosis | Phase 3 | 2008-06-01 |